Clinical Trials Browser

Phase 3 × HER2-positive Early Breast Cancer × Carboplatin × Clear all

NCT03989037 2023-12-27

A Study Of SIBP-01 Or CN-Trastuzumab Plus Docetaxel And Carboplatin In HER2 Positive Breast Cancer

Phase 3 Completed

HER2-positive Early Breast Cancer